Viewing Study NCT01434602

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-01-10 @ 12:51 PM
Study NCT ID: NCT01434602
Status: COMPLETED
Last Update Posted: 2022-06-01
First Post: 2011-09-13
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Tumor View
None Glioblastoma View
None Anaplastic Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chemotherapy View
None Brain Tumor View
None Glioblastoma View
None Anaplastic Glioma View